This metaanalysis showed that Ser217Leu and Ala541Thr polymorphism of ELAC2 gene is accompanied by increase of risk of prostate cancer and may be the markers which are sensitive to low penetration of the prostate cancer (Meitz et al., 2002). This evidence concerns the gene ELAC2 and prostate cancer.